Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Altus Pharmaceuticals Inc. > News item |
Altus Pharmaceuticals files $20 million shelf covering stock and debt
By Devika Patel
Knoxville, Tenn., June 23 - Altus Pharmaceuticals Inc. filed a $20 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers debt securities, preferred stock, common stock, units and warrants.
The securities may be structured as convertibles.
Proceeds will be used for general corporate purposes.
Altus is a Cambridge, Mass., biopharmaceutical company focused on oral and injectable protein therapeutics for gastrointestinal and metabolic disorders.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.